Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$133M |
| 2 |
AbbVie
ABBV
|
+$110M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$93.9M |
| 4 |
Amazon
AMZN
|
+$91.8M |
| 5 |
Otis Worldwide
OTIS
|
+$84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$226M |
| 2 |
RTN
Raytheon Company
RTN
|
+$145M |
| 3 |
WBC
WABCO HOLDINGS INC.
WBC
|
+$51.2M |
| 4 |
Newmont
NEM
|
+$50.7M |
| 5 |
Yum! Brands
YUM
|
+$33.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.6% |
| 2 | Healthcare | 15.16% |
| 3 | Consumer Discretionary | 12.49% |
| 4 | Communication Services | 10.41% |
| 5 | Industrials | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VG
1126
DELISTED
Vonage Holdings Corporation
VG
| $5.18M | ﹤0.01% |
515,100
+68,200
| +15% | +$612K |
|
|
SAFM
1127
DELISTED
Sanderson Farms Inc
SAFM
| $5.18M | ﹤0.01% |
44,700
+6,000
| +16% | +$771K |
|
|
WRI
1128
DELISTED
Weingarten Realty Investors
WRI
| $5.17M | ﹤0.01% |
272,900
+35,800
| +15% | +$626K |
|
1129
Fabrinet
FN
$20.3B
| $5.17M | ﹤0.01% |
82,740
+11,000
| +15% | +$675K |
|
|
TCO
1130
DELISTED
Taubman Centers Inc.
TCO
| $5.16M | ﹤0.01% |
136,700
+18,000
| +15% | +$736K |
|
|
SJI
1131
DELISTED
South Jersey Industries, Inc.
SJI
| $5.16M | ﹤0.01% |
206,309
+27,100
| +15% | +$714K |
|
|
ADSW
1132
DELISTED
Advanced Disposal Services Inc
ADSW
| $5.15M | ﹤0.01% |
170,600
+23,200
| +16% | +$740K |
|
1133
Papa John's
PZZA
$804M
| $5.15M | ﹤0.01% |
64,800
+24,500
| +61% | +$1.82M |
|
1134
Independent Bank
INDB
$4.05B
| $5.14M | ﹤0.01% |
76,678
+10,000
| +15% | +$672K |
|
|
TGNA
1135
DELISTED
TEGNA Inc
TGNA
| $5.12M | ﹤0.01% |
460,000
+39,300
| +9% | +$437K |
|
|
PACW
1136
DELISTED
PacWest Bancorp
PACW
| $5.12M | ﹤0.01% |
259,973
+30,700
| +13% | +$569K |
|
1137
California Water Service
CWT
$3.1B
| $5.12M | ﹤0.01% |
107,400
+14,000
| +15% | +$661K |
|
1138
Madison Square Garden
MSGS
$9.94B
| $5.12M | ﹤0.01% |
34,833
-7,273
| -17% | -$1.2M |
|
1139
H.B. Fuller
FUL
$3.24B
| $5.12M | ﹤0.01% |
114,700
+15,800
| +16% | +$573K |
|
1140
Axsome Therapeutics
AXSM
$11.2B
| $5.09M | ﹤0.01% |
61,900
+15,100
| +32% | +$1.16M |
|
1141
CNO Financial Group
CNO
$5.07B
| $5.08M | ﹤0.01% |
326,500
+33,400
| +11% | +$460K |
|
1142
Brink's
BCO
$4.72B
| $5.08M | ﹤0.01% |
111,700
+14,700
| +15% | +$670K |
|
1143
Federated Hermes
FHI
$4.74B
| $5.08M | ﹤0.01% |
214,417
+28,100
| +15% | +$622K |
|
1144
Merit Medical Systems
MMSI
$5.4B
| $5.06M | ﹤0.01% |
110,900
+3,800
| +4% | +$153K |
|
1145
Aaon
AAON
$7.23B
| $5.05M | ﹤0.01% |
139,575
+18,300
| +15% | +$615K |
|
1146
LendingTree
TREE
$461M
| $5.05M | ﹤0.01% |
17,450
+2,300
| +15% | +$556K |
|
|
MIC
1147
DELISTED
Macquarie Infrastructure Holdings, LLC
MIC
| $5.05M | ﹤0.01% |
164,500
+22,000
| +15% | +$609K |
|
1148
NovaGold Resources
NG
$3.4B
| $5.05M | ﹤0.01% |
554,000
+73,500
| +15% | +$744K |
|
1149
Assured Guaranty
AGO
$3.35B
| $5.04M | ﹤0.01% |
206,500
+21,500
| +12% | +$586K |
|
|
AEL
1150
DELISTED
American Equity Investment Life Holding Company
AEL
| $5.04M | ﹤0.01% |
203,800
+27,200
| +15% | +$567K |
|
Similar funds
Swiss National Bank's Q2 2020 Portfolio in Review
As of Q2 2020, Swiss National Bank held 2,599 positions worth $118B, up 26% from $94.2B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Swiss National Bank's Q2 2020 filing shows 119 new, 2,134 increased, 181 reduced and 161 closed positions. Its largest new stake was Otis Worldwide: 1,621,054 shares worth $92.2M. The largest sale was Allergan plc, an estimated $226M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q2 2020 buy was Otis Worldwide: 1,621,054 shares worth $92.2M.
- Swiss National Bank added most to Alibaba in Q2 2020, an estimated $133M increase.
- Swiss National Bank's biggest Q2 2020 reduction was Newmont, cutting an estimated $50.7M.
- Swiss National Bank fully exited Allergan plc in Q2 2020, selling an estimated $226M.
- Swiss National Bank's ten largest holdings make up 24% of its $118B portfolio in Q2 2020.
- Swiss National Bank opened 119 new positions and closed 161 in Q2 2020.
- Swiss National Bank's portfolio value rose 26% quarter-over-quarter to $118B.
Based on Swiss National Bank's 13F filing for Q2 2020, filed 5 Aug 2020.